NCT07007364: Neoadjuvant Low-Dose Radiotherapy Combined With Adebrelimab and Single-Agent Albumin-Bound Paclitaxel Chemotherapy for Early-Stage Oral Squamous Cell Carcinoma: A Prospective, Single-Arm Clinical Trial
- State
- Under way
- Phase
- Phase 2
- People
- 30 planned
- Started
- 19 Jun 2025
- Primary completion
- 1 Jun 2026
- Arms
- Neoadjuvant low-dose radiotherapy combined with adebrelimab and monotherapy with albumin paclitaxel
- Results
- None posted
- 5 Jun 2025: Trial registered